Sofosbuvir/ledipasvir plus ribavirin achieves high SVR12 in genotype‐3 patients with compensated cirrhosis and similar to sofosbuvir plus daclatasvir: a multicentre real life cohort
Ver/ abrir
Use este enlace para citar
http://hdl.handle.net/2183/21786Coleccións
Metadatos
Mostrar o rexistro completo do ítemTítulo
Sofosbuvir/ledipasvir plus ribavirin achieves high SVR12 in genotype‐3 patients with compensated cirrhosis and similar to sofosbuvir plus daclatasvir: a multicentre real life cohortAutor(es)
Data
2016-10Cita bibliográfica
Riveiro-Barcela M, Alonso S, Fernández I, et al. Sofosbuvir/ledipasvir plus ribavirin achieves high SVR12 in genotype‐3 patients with compensated cirrhosis and similar to sofosbuvir plus daclatasvir: a multicentre real life cohort. En: The 67th Annual Meeting of the American Association for the Study of Liver Diseases: the Liver Meeting 2016; 2016 Nov 11-15; Boston, Massachusetts. Hoboken, NJ: John Wiley & Sons; 2016. p. 464A (Heaptology. 2016; 64 Special issue 1)
Descrición
Poster abstract
Versión do editor
Dereitos
This is the peer reviewed version of the article which has been published in final form at Hepatology. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for self-archiving
ISSN
0270-9139